Skip to content
Clinical Trials – home

Meniere's disease Diagnostics

2 / 2 trials open to patients2 countries

In short

Diagnosing Meniere's disease can be challenging, as its symptoms resemble those of many other conditions affecting the inner ear and balance. There is no single test that confirms the diagnosis, which means doctors must carefully evaluate symptoms, conduct various examinations, and rule out other possible causes before reaching a conclusion.

Key points

  • Meniere's disease diagnosis requires at least two episodes of vertigo lasting 20 minutes to 12 hours, plus documented hearing loss and ear-related symptoms.[7][8]
  • There's no single test that confirms Meniere's disease—it's diagnosed by ruling out other conditions and evaluating symptom patterns over time.[7]
  • An ENT specialist (otolaryngologist) typically makes the diagnosis after performing hearing and balance tests.[2][9]
  • Hearing tests (audiometry) show a characteristic pattern in Meniere's disease, with difficulty hearing low-frequency sounds.[8]
  • Balance tests like VNG and VEMP help evaluate inner ear function by measuring eye movements and responses to stimulation.[8][12]
  • MRI scans don't diagnose Meniere's disease but help rule out other serious conditions like tumors that could cause similar symptoms.[4][5]
  • Clinical trials use stricter diagnostic criteria than regular practice to ensure participants truly have Meniere's disease.[7]
  • While Meniere's disease is lifelong and has no cure, it doesn't affect life expectancy, and symptoms can be managed effectively with proper treatment.[1][2]

Introduction: When to Seek Diagnostic Testing

If you experience recurring episodes of severe dizziness that make the room feel like it's spinning, hearing loss that comes and goes, ringing or buzzing sounds in one ear, or a feeling of pressure deep inside your ear, it's important to see your healthcare provider. These symptoms could indicate Meniere's disease, but they might also point to other conditions that need medical attention.

You should seek medical evaluation as soon as possible when these symptoms first appear, because early diagnosis helps in managing the condition better and can prevent complications. Many illnesses can cause similar problems, so finding out what's actually causing your symptoms is crucial. Don't wait for symptoms to become severe or more frequent before consulting a doctor.

People between the ages of 40 and 60 are most commonly affected by Meniere's disease, though it can develop at any age. If you have a family member with this condition, you may be at slightly higher risk, which is another reason to seek evaluation if you notice warning signs.

Classic Diagnostic Methods for Identifying Meniere's Disease

Diagnosing Meniere's disease is not straightforward because there isn't a single definitive test that can confirm it with absolute certainty. Instead, doctors rely on a combination of your medical history, reported symptoms, physical examination, and various tests to rule out other conditions. This is what makes Meniere's disease fundamentally what doctors call "a diagnosis of exclusion," meaning other possible causes must be eliminated first.

Your healthcare provider will perform a thorough examination and ask detailed questions about your health history. To meet the criteria for a definite Meniere's disease diagnosis, you must have experienced at least two or more episodes of vertigo (a spinning sensation) that each lasted between 20 minutes and 12 hours, or up to 24 hours. You must also have documented hearing loss shown by a hearing test, plus either ringing in the ears (called tinnitus) or a feeling of fullness or pressure in the affected ear. Importantly, these symptoms should not be better explained by another medical condition.

A specialist called an otolaryngologist, also known as an ENT (ear, nose, and throat doctor), typically makes the diagnosis. During your visit, the doctor will check inside your ears, examine your head and neck, and may ask you to perform simple exercises like marching in place or standing with your heels together and eyes closed to assess your balance.

Hearing Assessment Tests

A hearing test called audiometry is essential for diagnosing Meniere's disease. This test evaluates how well you can hear sounds at different pitches (frequencies) and volumes. It can also test your ability to distinguish between words that sound similar. People with Meniere's disease typically have a characteristic pattern: they often struggle to hear low-frequency sounds or have trouble with a combination of high and low frequencies, while their hearing in the middle range may be relatively normal.

At first, hearing loss in Meniere's disease may come and go, especially in the early stages of the condition. You might notice your hearing is muffled or blocked during an attack, then improves afterward. However, without proper management, this hearing loss can become permanent and progressively worsen over time.

Balance Assessment Tests

Between vertigo attacks, most people with Meniere's disease have normal balance. However, you might experience ongoing balance difficulties. Several specialized tests can evaluate how well your inner ear is functioning in terms of balance control.

Electronystagmography (ENG) or videonystagmography (VNG) are tests that measure balance by studying your eye movements. These tests have several parts: one examines how your eyes move while following a target, another studies eye movement when your head is placed in different positions, and a third part called the caloric test observes eye movement by using temperature changes (warm and cold air or water in the ear) to trigger a reaction from the inner ear.

Rotary-chair testing is another balance assessment method. Similar to VNG, it measures how well your inner ear functions by tracking eye movements. During this test, you sit in a computer-controlled chair that rotates from side to side, which stimulates your inner ear's balance system.

Vestibular Evoked Myogenic Potential (VEMP) is an additional test that can help confirm the diagnosis by measuring how specific parts of your inner ear respond to sound or vibration.

Electrocochleography (ECOG) is a specialized test that measures electrical activity in the inner ear in response to sound stimulation. This test can help detect the fluid buildup characteristic of Meniere's disease.

Imaging and Additional Tests

Doctors sometimes order an MRI (magnetic resonance imaging) scan to make sure something else isn't causing your symptoms. While there's no specific imaging test that definitively proves you have Meniere's disease, an MRI can help rule out other serious conditions such as tumors or structural problems in the brain or inner ear that might produce similar symptoms.

Blood tests may also be conducted to check for other underlying conditions that could be contributing to your symptoms, though there is no specific blood test for Meniere's disease itself.

Diagnostics for Clinical Trial Qualification

When researchers conduct clinical trials to test new treatments for Meniere's disease, they need to ensure that participants actually have the condition and meet specific criteria. This helps ensure that the trial results are reliable and applicable to people with Meniere's disease.

Clinical trials typically use the diagnostic criteria established by the Barany Society, which requires participants to have experienced at least two or more spontaneous episodes of vertigo lasting 20 minutes to 12 hours. Participants must also have documented hearing loss in the low- to medium-frequency range in one ear (the affected ear) that has been confirmed by audiometry testing. This hearing loss must have been present before, during, or after at least one episode of vertigo. Additionally, participants need to have fluctuating symptoms in the affected ear, such as fullness, hearing changes, or tinnitus. Finally, the symptoms should not be better explained by another condition or diagnosis.

To qualify for a clinical trial, participants usually need to undergo a comprehensive hearing test (audiometry) to document the type and degree of hearing loss. This establishes a baseline that researchers can use to measure whether a treatment is helping. Balance function tests such as VNG or VEMP may be required to objectively measure the extent of balance system dysfunction before treatment begins.

Some trials may require imaging studies like MRI to rule out other causes of symptoms and ensure participants truly have Meniere's disease rather than another condition. Detailed medical history documentation is also essential, including information about the frequency and severity of vertigo attacks, progression of hearing loss, and how symptoms impact daily life.

Researchers may also assess participants' overall health status and check for other medical conditions that could interfere with the trial. For example, if a trial is testing a medication, participants might need blood tests or other evaluations to ensure they can safely receive the treatment being studied.

Prognosis and Survival Rate

Prognosis

Meniere's disease is considered a lifelong condition, but the outlook varies considerably from person to person. While there is currently no cure, many people learn to manage their symptoms effectively with the right combination of treatments and lifestyle changes. The unpredictable nature of the disease means that some individuals experience frequent attacks clustered together over several days, while others have single episodes separated by long periods without symptoms.

Over time, the frequency of vertigo attacks often decreases naturally. However, this doesn't necessarily mean the disease is improving overall. Hearing loss typically progresses gradually and can become permanent, usually affecting one ear, though in about 15 to 25 percent of people with Meniere's disease, both ears may eventually be involved. After approximately eight to ten years, many people develop permanent hearing loss in the affected ear.

The condition can significantly impact daily activities and quality of life. Severe vertigo attacks can lead to dangerous falls and make activities like driving, climbing ladders, or operating machinery too risky to attempt. Some people experience "drop attacks," where vertigo is so extreme that they suddenly fall without warning. The unpredictability of when attacks will occur can lead to anxiety and depression, as people worry about having an episode in public or during important activities.

With proper treatment and management, many people find that their symptoms become more controlled and less disruptive to their lives. Working closely with healthcare providers to find effective strategies—including medications, dietary changes, and other interventions—can help improve the prognosis and allow individuals to maintain a good quality of life despite having the condition.

Survival rate

Meniere's disease is not a life-threatening condition, and it does not affect life expectancy. People with Meniere's disease have the same survival rates as the general population. The disease affects the inner ear and causes symptoms related to balance and hearing, but it does not spread to other parts of the body or cause organ failure. However, the severe vertigo attacks can lead to serious injuries from falls, which is why safety precautions and proper management are important.

Did you know?

  1. Meniere's disease was first identified in 1861 by French physician Prosper Ménière, who discovered that these symptoms originated in the inner ear rather than the brain, as doctors previously believed.[6]
  2. Although the exact cause remains unknown, some people with Meniere's disease have a family history of the condition, with about 7 to 10 percent of patients having relatives who also have the disorder, suggesting a possible genetic component.[2][9]
  3. Approximately 615,000 people in the United States currently have Meniere's disease, with about 45,500 new cases diagnosed each year, making it a relatively rare disorder affecting only about 0.2 percent of the population.[3][6]

Questions people often ask

This guide is here to help you understand the condition. It does not replace a conversation with your doctor, who knows your situation best.

Clinical trials for Meniere's disease

Recruiting trials first

See all 2 trials →
Quick filters

2 clinical trials in this condition

Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Dexamethasone
  • Sponsor:Leids Universitair Medisch Centrum (LUMC)
Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Betahistine Dihydrochloride
  • Sponsor:Intas Pharmaceuticals Limited
See all 2 trials →filters applied: condition = Meniere's disease

Related conditions in the same therapeutic area

Back to all diseases
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).